CapVest to buy control of generics giant Stada in €10bn deal
The majority stake transaction marks one of the largest deals in healthcare this year amid a tepid private equity landscape.
deal
Immedica to buy Marinus Pharmaceuticals for $151m
Investors optimistic about continued biotech and medtech IPO resurgence in 2025
AlloVir and Kalaris enter merger to advance retinal disease therapies
Sanofi’s $17bn sale of Opella to US investors advances following government deal
Sanofi signs radioligand therapy licensing deal for rare cancers
UCB to divest China neurology and allergy business for $680m
Rafael Holdings and Cyclo Therapeutics enter merger deal
